Results 161 to 170 of about 3,281 (174)

Treatment of Chronic Immune Thrombocytopenia in Children With Romiplostim

Lancet, The, 2016
Shruti Chaturvedi, Keith R McCrae
exaly  

Integrated Analysis of Long-Term Safety in Patients With Chronic Immune Thrombocytopaenia (ITP) Treated With the Thrombopoietin (TPO) Receptor Agonist Romiplostim

International Journal of Hematology, 2015
Douglas Cines, Drew Provan, Bertrand Godeau   +2 more
exaly  

Romiplostim in Children With Chronic Refractory ITP: Randomized Placebo Controlled Study

Annals of Hematology, 2011
Mohsen Elalfy, Abeer Ahmed Abdelmaksoud
exaly  

Romiplostim-Induced Myelofibrosis

Blood, 2013
Armin Rashidi
exaly  

A Large Observational Study of Patients With Primary Immune Thrombocytopenia Receiving Romiplostim in European Clinical Practice

European Journal of Haematology, 2017
Georgia D Kaiafa, Ann Janssens, Philippe Quittet   +2 more
exaly  

Remission and Platelet Responses With Romiplostim in Primary Immune Thrombocytopenia: Final Results From a Phase 2 Study

British Journal of Haematology, 2016
Adrian Newland, Melissa Eisen
exaly  

Evaluation of Bleeding and Thrombotic Events During Long-Term Use of Romiplostim in Patients With Chronic Immune Thrombocytopenia (ITP)

Journal of Thrombosis and Haemostasis, 2010
L M Aledort, L M Aledort, J L Nichol
exaly  

A Phase II, Open-Label, Sequential-Cohort, Dose-Escalation Study of Romiplostim in Japanese Patients With Chronic Immune Thrombocytopenic Purpura

International Journal of Hematology, 2009
Yukari Shirasugi, Yoshiyuki Kurata, Dietmar P Berger   +2 more
exaly  

Results of a Randomized, Double-Blind Study of Romiplostim Versus Placebo in Patients With Low/Intermediate-1–Risk Myelodysplastic Syndrome and Thrombocytopenia

Cancer, 2014
Pierre Fenaux, Andrea Kuendgen, Hagop Kantarjian   +2 more
exaly  

Development of Romiplostim for Treatment of Primary Immune Thrombocytopenia From a Pharmacokinetic and Pharmacodynamic Perspective

Clinical Pharmacokinetics, 2016
Andrew T Chow
exaly